Advanced Recurrent Hepatocellular Carcinoma: Treatment with Sorafenib Alone or in Combination with Transarterial Chemoembolization and Radiofrequency Ablation
Zhenwei Peng(Sun Yat-sen University), Ming Kuang(Sun Yat-sen University), Jiaping Li(Sun Yat-sen University), Mengchao Wei(Sun Yat-sen University), Bin Li(Sun Yat-sen University), Yu Wang(Medical Research Council), Xiaoyan Xie(Sun Yat-sen University), Chunlin Jiang(The First Affiliated Hospital, Sun Yat-sen University), Shuling Chen(Jiangsu University of Science and Technology), Minshan Chen(Sun Yat-sen University), Jie Mei(Sun Yat-sen University), Guojun Qian(Sun Yat-sen University), Manxia Lin(Sun Yat-sen University)
Cited by 74
Related Papers
Global patterns of hepatocellular carcinoma management from diagnosis to death: the <scp>BRIDGE</scp> Study
|Liver International|2015|1.3k
The prognostic significance of the prognostic nutritional index in cancer: a systematic review and meta-analysis
|Journal of Cancer Research and Clinical Oncology|2014|414
Ultrasound-based radiomics score: a potential biomarker for the prediction of microvascular invasion in hepatocellular carcinoma
|European Radiology|2018|201